Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

(2016) Per Ljungman et al.   CLINICAL INFECTIOUS DISEASES

ECIL guidelines for the diagnosis ofPneumocystis jiroveciipneumonia in patients with haematological malignancies and stem cell transplant recipients

(2016) Alexandre Alanio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation

(2016) Déla Golshayan et al.   KIDNEY INTERNATIONAL

Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy

(2015) A. M. Eiden et al.   CLINICAL CANCER RESEARCH

Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients

(2014) Pierre Fillatre et al.   AMERICAN JOURNAL OF MEDICINE

Risk Factors ofPneumocystisPneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis

(2014) X. Iriart et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data

(2014) G. A. Knoll et al.   BMJ-British Medical Journal

PneumocystisPneumonia in Solid Organ Transplantation

(2013) S. I. Martin et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort

(2013) Michael T. Koller et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Pneumocystis Jirovecii Pneumonia in Renal Transplant Recipients: A National Center Experience

(2013) S. Borstnar et al.   TRANSPLANTATION PROCEEDINGS

Outbreaks of Pneumocystis Pneumonia in 2 Renal Transplant Centers Linked to a Single Strain of Pneumocystis: Implications for Transmission and Virulence

(2012) M. Sassi et al.   CLINICAL INFECTIOUS DISEASES

A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection

(2012) R. U. Pliquett et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Pneumocystispneumonia in solid organ transplant recipients: not yet an infection of the past

(2012) E.H.Z. Wang et al.   Transplant Infectious Disease

Quantitative PCR to diagnosePneumocystispneumonia in immunocompromised non-HIV patients

(2011) K. Mühlethaler et al.   EUROPEAN RESPIRATORY JOURNAL

Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis

(2011) S. Anand et al.   Transplant Infectious Disease

Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis

(2011) M.G.J. de Boer et al.   Transplant Infectious Disease

Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study

(2010) N. De Castro et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients

(2010) F. Eitner et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary

(2009) Bertram L. Kasiske et al.   KIDNEY INTERNATIONAL

Analysis of USRDS: Incidence and Risk Factors for Pneumocystis jiroveci Pneumonia

(2009) Robert T. Neff et al.   TRANSPLANTATION